Bristol Myers Squibb reports double-digit growth in Q3
US-based Bristol Myers Squibb's revenue in the third quarter of the year has gone up 10 percent to USD 11.6bn and surpassed analyst estimates, reports Bloomberg News.
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
The US-based pharmaceutical giant Bristol Myers Squibb has seen progress in the year's third quarter, increasing product revenue for several of its drugs, it reported in a press release on Wednesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Rhovac is open to all sale and partnership opportunities
For subscribers
.jpg&w=384&q=75)
